Immuneering Corporation Class A Common Stock (IMRX) Stock Price
Immuneering Corporation Class A Common Stock (NASDAQ: IMRX) last traded at $5.30, up 0.95% on the session. The quote above updates while this page is open; the figures below are drawn from Immuneering Corporation Class A Common Stock’s own filings and are restated only when a new one is published.
Immuneering Corporation Class A Common Stock (IMRX) company overview
Immuneering Corporation Class A Common Stock trades on NASDAQ under the ticker IMRX. Its market capitalisation is $342.90 million.
IMRX valuation
Valuation measures for Immuneering Corporation Class A Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$342.90M
Enterprise value
$312.89M
Price / book
1.80
Beta
1.07
IMRX financials
Trailing-twelve-month figures tagged in Immuneering Corporation Class A Common Stock's XBRL filings with the SEC.
Net income (TTM)
-$57.28M
EPS (TTM)
-$0.930
Return on equity
-30.03%
Cash
$41.32M
IMRX trading statistics
Range and volume for IMRX over the past 52 weeks.
52-week high
$10.08
52-week low
$3.86
Volume
443.6K
Average volume
1.49M
Previous close
$5.25
Immuneering Corporation Class A Common Stock (IMRX) FAQs
What is the IMRX stock price today?
Immuneering Corporation Class A Common Stock (IMRX) last traded at $5.30, up 0.95% on the session. FurlPay quotes IMRX from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is IMRX listed on?
Immuneering Corporation Class A Common Stock is listed on NASDAQ under the ticker symbol IMRX.
What is Immuneering Corporation Class A Common Stock's market cap?
Immuneering Corporation Class A Common Stock has a market capitalisation of $342.90 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is IMRX's 52-week range?
Over the past 52 weeks IMRX has traded between $3.86 and $10.08.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001790340), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
IMRX Stock Price & Quote | Immuneering Corporation Class A Common Stock | FurlPay